glp-1 drugs review The New The GLP-1 Agonists and Obesity:

Question 4: what other conditions besides obesity may contribute to the development of hepatic steatosis

1 Introduction Obstructive sleep apnea syndrome (OSAS) is a chronic sleep-related breathing disorder characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxemia, sleep architecture disruption, and impaired daytime functioning (1, 2)

In alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, Placebo-Controlled, double-blind clinical trial

[DOI] [PubMed] [Google Scholar] 100.Drucker DJ

This medication can also help lower the risk of cardiovascular events like stroke or heart attack in people with type 2 diabetes and heart disease

consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim and Novo Nordisk